These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 37358009)
1. Targeting PTGES/PGE2 axis enhances sensitivity of colorectal cancer cells to 5-fluorouracil. Geng S; Zhan H; Cao L; Geng L; Ren X Biochem Cell Biol; 2023 Dec; 101(6):501-512. PubMed ID: 37358009 [TBL] [Abstract][Full Text] [Related]
2. Casein Kinase 2α Enhances 5-Fluorouracil Resistance in Colorectal Cancer Cells by Inhibiting Endoplasmic Reticulum Stress. Kim HJ; Han YS; Lee JH; Lee SH Anticancer Res; 2020 Mar; 40(3):1419-1426. PubMed ID: 32132038 [TBL] [Abstract][Full Text] [Related]
3. Andrographis overcomes 5-fluorouracil-associated chemoresistance through inhibition of DKK1 in colorectal cancer. Zhao Y; Wang C; Goel A Carcinogenesis; 2021 Jun; 42(6):814-825. PubMed ID: 33822896 [TBL] [Abstract][Full Text] [Related]
4. Reactivating p53 and Inducing Tumor Apoptosis (RITA) Enhances the Response of RITA-Sensitive Colorectal Cancer Cells to Chemotherapeutic Agents 5-Fluorouracil and Oxaliplatin. Wiegering A; Matthes N; Mühling B; Koospal M; Quenzer A; Peter S; Germer CT; Linnebacher M; Otto C Neoplasia; 2017 Apr; 19(4):301-309. PubMed ID: 28284059 [TBL] [Abstract][Full Text] [Related]
5. ZBTB7 evokes 5-fluorouracil resistance in colorectal cancer through the NF‑κB signaling pathway. Wang Z; Zhao X; Wang W; Liu Y; Li Y; Gao J; Wang C; Zhou M; Liu R; Xu G; Zhou Q Int J Oncol; 2018 Nov; 53(5):2102-2110. PubMed ID: 30106136 [TBL] [Abstract][Full Text] [Related]
6. Chemosensitization of HT29 and HT29-5FU Cell Lines by a Combination of a Multi-Tyrosine Kinase Inhibitor and 5FU Downregulates ABCC1 and Inhibits PIK3CA in Light of Their Importance in Saudi Colorectal Cancer. Abdalla AN; Malki WH; Qattan A; Shahid I; Hossain MA; Ahmed M Molecules; 2021 Jan; 26(2):. PubMed ID: 33440689 [TBL] [Abstract][Full Text] [Related]
7. METTL3 antagonizes 5‑FU chemotherapy and confers drug resistance in colorectal carcinoma. Li M; Xia M; Zhang Z; Tan Y; Li E; Guo Z; Fang M; Zhu Y; Hu Z Int J Oncol; 2022 Sep; 61(3):. PubMed ID: 35856434 [TBL] [Abstract][Full Text] [Related]
8. PGC-1α Controls Mitochondrial Biogenesis in Drug-Resistant Colorectal Cancer Cells by Regulating Endoplasmic Reticulum Stress. Yun CW; Han YS; Lee SH Int J Mol Sci; 2019 Apr; 20(7):. PubMed ID: 30959809 [TBL] [Abstract][Full Text] [Related]
9. CCAAT/enhancer binding protein β regulates prostaglandin E synthase expression and prostaglandin E2 production in activated microglial cells. Straccia M; Dentesano G; Valente T; Pulido-Salgado M; Solà C; Saura J Glia; 2013 Oct; 61(10):1607-19. PubMed ID: 23893854 [TBL] [Abstract][Full Text] [Related]
10. AKR1C4 regulates the sensitivity of colorectal cancer cells to chemotherapy through ferroptosis modulation. Wang L; Lv C; Liu X Cancer Chemother Pharmacol; 2024 Sep; 94(3):373-385. PubMed ID: 38890190 [TBL] [Abstract][Full Text] [Related]
11. Investigating the role of nucleoside transporters in the resistance of colorectal cancer to 5-fluorouracil therapy. Phua LC; Mal M; Koh PK; Cheah PY; Chan EC; Ho HK Cancer Chemother Pharmacol; 2013 Mar; 71(3):817-23. PubMed ID: 23271323 [TBL] [Abstract][Full Text] [Related]
12. SNAI2 modulates colorectal cancer 5-fluorouracil sensitivity through miR145 repression. Findlay VJ; Wang C; Nogueira LM; Hurst K; Quirk D; Ethier SP; Staveley O'Carroll KF; Watson DK; Camp ER Mol Cancer Ther; 2014 Nov; 13(11):2713-26. PubMed ID: 25249558 [TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice. Wang D; Fu L; Sun H; Guo L; DuBois RN Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008 [TBL] [Abstract][Full Text] [Related]
14. Long-term resistance to 5-fluorouracil promotes epithelial-mesenchymal transition, apoptosis evasion, autophagy, and reduced proliferation rate in colon cancer cells. Sousa-Squiavinato ACM; Arregui Ramos DA; Wagner MS; Tessmann JW; de-Freitas-Junior JCM; Morgado-Díaz JA Eur J Pharmacol; 2022 Oct; 933():175253. PubMed ID: 36067803 [TBL] [Abstract][Full Text] [Related]
15. PTGES/PGE Wang T; Jing B; Xu D; Liao Y; Song H; Sun B; Guo W; Xu J; Li K; Hu M; Liu S; Ling J; Kuang Y; Zhang T; Zhang S; Yao F; Zhou BP; Deng J Oncogene; 2020 Apr; 39(15):3179-3194. PubMed ID: 32060421 [TBL] [Abstract][Full Text] [Related]
16. Curcumin mediates chemosensitization to 5-fluorouracil through miRNA-induced suppression of epithelial-to-mesenchymal transition in chemoresistant colorectal cancer. Toden S; Okugawa Y; Jascur T; Wodarz D; Komarova NL; Buhrmann C; Shakibaei M; Boland CR; Goel A Carcinogenesis; 2015 Mar; 36(3):355-67. PubMed ID: 25653233 [TBL] [Abstract][Full Text] [Related]
17. Nuclear orphan receptor NR4A2 confers chemoresistance and predicts unfavorable prognosis of colorectal carcinoma patients who received postoperative chemotherapy. Han Y; Cai H; Ma L; Ding Y; Tan X; Liu Y; Su T; Yu Y; Chang W; Zhang H; Fu C; Cao G Eur J Cancer; 2013 Nov; 49(16):3420-30. PubMed ID: 23809767 [TBL] [Abstract][Full Text] [Related]
18. HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy. Nagaraju GP; Alese OB; Landry J; Diaz R; El-Rayes BF Oncotarget; 2014 Oct; 5(20):9980-91. PubMed ID: 25296971 [TBL] [Abstract][Full Text] [Related]
19. HIPK2 is a potential predictive marker of a favorable response for adjuvant chemotherapy in stage II colorectal cancer. Verdina A; Di Segni M; Amoreo CA; Sperduti I; Buglioni S; Mottolese M; Di Rocco G; Soddu S Oncol Rep; 2021 Mar; 45(3):899-910. PubMed ID: 33650652 [TBL] [Abstract][Full Text] [Related]
20. Knockdown of long non‑coding RNA PVT1 reverses multidrug resistance in colorectal cancer cells. Fan H; Zhu JH; Yao XQ Mol Med Rep; 2018 Jun; 17(6):8309-8315. PubMed ID: 29693171 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]